A.D.V.A.N.C.E.ᵀᴹ TRANSFORMATION IN LIFE SCIENCE
OUR MISSION
The Market Gap: A critical disparity exists between the capital required by early-stage life science companies and the risk tolerance of traditional operating partners. This gap leaves many high-value assets under-resourced at pivotal moments, limiting their ability to generate data, reach clinical milestones, and advance toward commercialization.
Enabling Growth:We provide incremental, milestone-driven capital designed to support near-term clinical development objectives. By structuring capital to match critical development needs, we help companies advance efficiently toward key value inflection points while managing risk.
Partnership Beyond Capital: We go beyond the initial investment by working alongside management teams as active partners. Through hands-on guidance, commercial expertise, and strategic support, we help companies accelerate progress, de-risk development, and position themselves to attract future investment.
ELEVATING INFLECTION POINTS FOR PORTFOLIO COMPANIES
RCP Venture Capital is an emerging fund built on the foundation of deep commercialization expertise. We partner with innovative biotech and medical device companies—particularly those advancing through clinical development—to accelerate their path to market and maximize value creation. Leveraging the experience and networks of Rapid Commercialization Partners, RCP VC combines strategic capital with hands-on support in market access, regulatory, medical affairs, and commercial strategy. With a flexible investment model that includes both a core venture fund and SPV structures, RCP Venture Capital is uniquely positioned to connect high-potential companies with the capital, insights, and partnerships they need to thrive. while building durable long-term value.
COMMERCIALIZATION EXPERTISE
At RCP Venture Capital, we combine investment with hands-on commercialization expertise to help portfolio companies reach their next milestone. Our team brings deep experience in Commercial Strategy, Market Access, Medical Affairs, and Regulatory giving companies the operational edge to accelerate approvals, build credibility, and drive adoption. By pairing capital with proven execution, we help transform clinical-stage innovation into commercial success.
AREAS OF FOCUS
Therapeutics
We partner with companies developing novel drugs, biologics, and advanced therapies, with a strong track record in rare and orphan diseases, oncology, neurology, and cardiology
Diagnostics
We support innovators creating precision diagnostics, companion tests, and advanced biomarker platforms that enable earlier detection and smarter clinical decisions.
Medical Device
Our experience spans implantables, surgical tools, and combination products, helping device companies navigate complex regulatory and adoption pathways.
Health Tech
We work with digital health, AI-enabled platforms, and connected care solutions that are transforming how patients, providers, and payers engage with healthcare.
MEET OUR MANAGING PARTNERS
Christina J. Ansted, MPH, CCMEP
Managing Partner
Christina is a seasoned biotechnology executive with deep experience guiding emerging life sciences companies through complex commercialization challenges. She brings a rigorous, outcomes-focused approach to strategy and execution, helping organizations optimize readiness, build high-performing teams, and accelerate the path from development to market.
Her background spans global commercialization and marketing, shared medical services, and medical and scientific communications, with particular strength in patient identification, diagnostic strategy, and launch planning. Christina is driven by a commitment to improving the success rate of innovative therapies and advancing meaningful treatments to patients more efficiently.
Michael Janes
Managing Partner
Michael is an experienced business development and life sciences executive with deep expertise in driving growth, strategic partnerships, and commercialization success across biotech. As Managing Partner of RCP Venture Capital, Michael bridges the gap between innovative science and commercial viability by aligning visionary founders with capital, operational resources, and go-to-market expertise. With extensive experience working alongside emerging and mid-stage companies, Michael excels in building strategic collaborations with venture capital and private equity investors to accelerate clinical-stage innovation and unlock value at key inflection points. Michael brings a unique combination of commercial strategy, investor relations, and operational leadership to every engagement — empowering life sciences companies to navigate complex development pathways and achieve meaningful impact.
INTEGRATED COMMERCIALIZATION PLATFORM
RCP Venture Capital works closely alongside Rapid Commercialization Partners (RCP), an independent life sciences commercialization firm with deep experience supporting companies from early clinical development through launch and scale. Through this relationship, portfolio companies benefit from access to seasoned operational leadership and commercialization expertise spanning market access, medical affairs, regulatory strategy, and core commercial execution.
This collaboration enables companies to align capital with execution, accelerate progress toward key milestones, and make more informed strategic decisions as they advance toward commercialization.
HOW TO FIND US
Located in the heart of Harvard Square in Cambridge, Massachusetts, this location sits at the epicenter of the global biotech and life sciences ecosystem. Surrounded by leading academic institutions, innovative startups, and world-class investors, Harvard Square is a hub where scientific discovery, commercialization, and capital converge—making it an ideal place to build, collaborate, and grow.